ArticlePloS one2025
Safety and contribution of elderly whole blood donors after raising the upper age limit: Hemovigilance data from a Chinese region from 2012 to 2023.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2012, China raised the upper age restriction for blood donors from 55 to 60 years old. This study analyzed the impact of raising the upper age restriction on whole blood donor health, contribution to blood supply, and safety of blood.
methodsThe blood collection and donor hemovigilance data of the Chongqing Blood Center from 2012 to 2023 were analyzed to evaluate the safety of elderly blood donors. To evaluate the impact on blood donor and blood component safety, the number of blood donors and donations, the rate and causes of deferrals, donor health (vasovagal reaction risk), and the screening results of transfusion-transmitted infectious diseases of elderly blood donors (56-60 years) were compared to young blood donors (18-55 years).
resultsDuring the 12-year period, the proportion of elderly blood donors in whole blood donations increased 10-fold (0.19% to 1.89%), and the proportion of blood collections increased by the same factor (0.20% to 2.15%). Lower deferral rates were observed among older male donors compared to younger ones, whereas the reverse was found in females. A lower incidence of vasovagal reactions and positive HBV, HCV, and syphilis screening rates was found among male and female elderly blood donors compared to young blood donors. In contrast, the positive HIV reaction rate of older female donors was higher than that of young female blood donors.
conclusionThis study finds an increasing frequency of donors aged 56-60. Deferral rates are lower among older male donors compared to young, but the reverse is seen in females. In addition, VVR rates and HCV, HBV and syphilis incidences are lower in old donors, but HIV rates appear highest among older donors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.